1,296 results on '"Pastorino, Ugo"'
Search Results
52. Supplementary Table 2 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
53. Supplementary Table 1 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
54. Supplementary Figure 6 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
55. Supplementary Figure 3 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
56. Supplementary Figure 8 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
57. Supplementary Table 3 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
58. Supplementary Figure 5 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
59. Supplementary Figure 7 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
60. Data from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
61. Supplementary Figure 1 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
62. Data from Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
63. Supplementary Figure 2 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
64. Supplementary Table S2 from Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
65. Supplementary Figure 4 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
66. Ascl1 and OTP tumour expressions are associated with disease‐free survival in lung atypical carcinoids
67. Long term outcome of complex surgical resection and reconstruction for rare thoracic cancers
68. Diagnosis and management of typical and atypical lung carcinoids
69. Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer
70. sj-pdf-1-tmj-10.1177_03008916231154763 – Supplemental material for Long term outcome of complex surgical resection and reconstruction for rare thoracic cancers
71. Refining Strategies to Identify Populations to Be Screened for Lung Cancer
72. A Prognostic Model Including Pre- and Postsurgical Variables to Enhance Risk Stratification of Primary Mediastinal Nonseminomatous Germ Cell Tumors: The 27-Year Experience of a Referral Center
73. Prognostic Factors Across Poorly Differentiated Neuroendocrine Neoplasms: a Pooled Analysis
74. Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
75. Evaluation of Simplified Diet Scores Related to C-Reactive Protein in Heavy Smokers Undergoing Lung Cancer Screening
76. Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
77. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied
78. Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications
79. Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
80. Increased serum levels of KiSS1-derived peptides in non-small cell lung cancer patient liquid biopsies and biological relevance
81. Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
82. Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis
83. Systematic Review of Multiple Studies of Prognosis: The Feasibility of Obtaining Individual Patient Data
84. Fuzzy k-NN Lung Cancer Identification by an Electronic Nose
85. Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
86. Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants
87. MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner
88. Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules
89. Abstract 1539: LKB1 down-modulation by miR-17 biologically and clinically mirrors LKB1-mutated NSCLC
90. Abstract 3377: Immunosuppressive features characterize tumor tissues and peripheral blood of lung cancer patients
91. Predictive value of automated coronary calcium scoring in lung cancer screening with low dose computed tomography
92. Phase III study with atezolizumab versus placebo in patients with malignant pleural mesothelioma after pleurectomy/decortication (AtezoMeso study).
93. Outcome of complex surgical resection and reconstruction for rare thoracic cancers: the clinical value of a predictive score
94. Increased mean lung density: Another independent predictor of lung cancer?
95. Current Status of Lung Cancer Screening
96. Granulated sugar in the complex management of empyema from broncho-pleural fistula
97. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
98. Annual or biennial CT screening versus observation in heavy smokers : 5-year results of the MILD trial
99. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma
100. MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.